Mansanades, Juliet J.

HRN: 22-77-07  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/31/2023
04/06/2023
IV
4.5gms
Q8
Empirical Escalation
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: